Adial Pharmaceuticals, Inc. (ADIL)
Develops medications to treat alcohol addiction and other substance use disorders.
$2.90+0.03%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-74.8%
The outlook
ADIL is trading near the bottom of its 52-week range, with analyst sentiment leaning bearish overall. The stock sits well below its average price target, though coverage appears thin. Price momentum is mixed against key moving averages.
What’s behind the score
Price trendMixed vs its moving averages
52-week range9% of the way from its 52-week low to high
Price targetAvg target +141% vs current price
Analyst price target
~12-month · 2 analysts$7.00average target+141.4% vs now
Now $2.90
Low $6.00High $8.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$6.3M
52-wk high
$19.00
52-wk low
$1.31
50-day avg
$2.52
200-day avg
$4.29
Trailing P/E
—